OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
63 hedge funds and large institutions have $33.7M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
63
Holding in Top 10
–
Calls
$35K
Puts
$35K
Top Buyers
| 1 | +$265K | |
| 2 | +$56K | |
| 3 | +$52.6K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$51K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42K |
Top Sellers
| 1 | -$459K | |
| 2 | -$348K | |
| 3 | -$177K | |
| 4 |
Renaissance Technologies
New York
|
-$159K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$117K |